Effect of in vivo administration of anti-CLTA-4 mAb and stimulatory anti-CD40 mAb on the induction of low dose oral tolerance

被引：0
|
作者：
Burns, R [1 ]
Rappold, K [1 ]
机构：
[1] Thomas More Coll, Crestview Hills, KY 41017 USA
来源：
FASEB JOURNAL | 2005年 / 19卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：A949 / A949
页数：1
相关论文
共 50 条
  • [41] THE ROLE OF TYROSINE PHOSPHORYLATION IN THE INDUCTION OF IGE SYNTHESIS BY INTERLEUKIN-4 AND ANTI-CD40
    LOH, RKS
    JABARA, HH
    GEHA, RS
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1993, 91 (01) : 235 - 235
  • [42] THE ROLE OF TYROSINE PHOSPHORYLATION IN THE INDUCTION OF IGE SYNTHESIS BY INTERLEUKIN-4 AND ANTI-CD40
    LOH, RKS
    VERCELLI, D
    GEHA, RS
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1992, 89 (01) : 312 - 312
  • [43] BIIB063, a Potent Anti-CD40 Antagonistic Monoclonal Antibody (MAb): Lessons Learned from an Early Development Program.
    Musselli, Cristina
    Harper, Claudia
    Burkly, Linda
    Lane, Joan
    Chen, Chase
    Donaldson, Dough
    Arefayene, Million
    Smirnakis, Karen
    Mehta, Devangi
    Morris, Dale
    Franchimont, Nathalie
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [44] CNI-FREE THERAPY WITH ISCALIMAB (ANTI-CD40 MAB) PRESERVES ALLOGRAFT HISTOLOGY COMPARED TO STANDARD OF CARE AFTER KIDNEY TRANSPLANTATION
    Farkash, Evan
    Naik, Abhijit
    Silva, Helio Tedesco
    Nashan, Bjoern
    Witzke, Oliver
    vandenHoogen, Martijn
    Berger, Stefan
    Cibrik, Diane
    Mulgaonkar, Shamkant
    Leeser, David B.
    Alloway, Rita
    Patel, Anita
    Pratschke, Johann
    Sommerer, Claudia
    Wiseman, Alexander
    vanZuilen, Arjan
    Laessing, Ute
    Haraldsson, Boerje
    Rush, James
    TRANSPLANT INTERNATIONAL, 2019, 32 : 62 - 62
  • [45] Anti-CD40 mAb Promotes Kidney Immunoregulatory Capacity in NHP Transplants by Altering Kidney Tubular Cell (TEC) Expression of CD40 and IL-6
    Arp, J.
    Ma, Y.
    Yang, H.
    El Warrak, A.
    Haig, A.
    Liu, W.
    Reimann, K.
    Luke, P.
    Zhang, Z.
    Rothstein, D.
    Jevnikar, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 : 343 - 343
  • [46] A phase I open-label, dose escalation of YH003, an anti-CD40 monoclonal antibody, in combination with toripalimab (anti-PD-1 mAb) in patients with advanced solid tumors
    Coward, Jermaine
    Ben Markman
    Nagrial, Adnan
    Abed, Afaf
    Walpole, Imogen
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [47] Cyclophosphamide induced CD11b+ cells can inhibit anti-CD40 monoclonal antibody (mAb) therapy of B-cell lymphoma
    Honeychurch, J
    Glennie, MJ
    Johnson, PW
    Illidge, TM
    BLOOD, 2004, 104 (11) : 896A - 896A
  • [48] EFFECT OF ANTI-CD4 AND ANTI-ICAM MAB ON SURVIVAL OF FETAL PIG PANCREAS GRAFTS IN NOD MICE
    KOULMANDA, M
    MANDEL, TE
    TRANSPLANTATION PROCEEDINGS, 1994, 26 (06) : 3466 - 3466
  • [49] Mechanisms and Rescue Strategies of Calcineurin Inhibitor Mediated Tolerance Abrogation Induced by Anti-CD4 mAb Treatment
    Siepert, A.
    Broesel, S.
    Vogt, K.
    Ahrlich, S.
    Schmitt-Knosalla, I.
    Loddenkemper, C.
    Kuehl, A.
    Baumgrass, R.
    Gerstmayer, B.
    Tomiuk, S.
    Tiedge, M.
    Viklicky, O.
    Brabcova, I.
    Nizze, H.
    Lehmann, M.
    Volk, H. -D.
    Sawitzki, B.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 (09) : 2308 - 2321
  • [50] Phase I open-label, dose escalation of YH003, an anti-CD40 monoclonal antibody in combination with toripalimab (anti-PD-1 mAb) in patients with advanced solid tumors.
    Coward, Jermaine
    Abed, Afaf
    Nagrial, Adnan
    Markman, Ben
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
12345